Combined oxidative phosphorylation defect type 5 (disorder) | | Combined oxidative phosphorylation defect type 5 | | Hypotonia with lactic acidemia and hyperammonemia COXPD5 - combined oxidative phosphorylation defect 5
| | This syndrome is characterized by severe hypotonia, lactic acidemia and congenital hyperammonemia. It has been described in three newborns born to consanguineous parents. Ultrasound examination during the 36th week of pregnancy revealed generalized edema. Hypertrophic cardiomyopathy and tubulopathy developed within the first week of life and the infants died within the first month. The activities of enzymes in the mitochondrial respiratory chain were reduced in the muscles of the patients. Mutations were identified in the MRPS22 gene on chromosome 3q23, encoding a mitochondrial ribosomal protein | | gecombineerd defect in oxidatieve fosforylering type 5 | | gecombineerd defect in OXPHOS type 5 COXPD5
|
| Id | 724279004 | Status | Primitive |
DHD Diagnosis thesaurus reference set |
ICD-10 complex map reference set | Target | E88.8 | Rule | TRUE | Advice | ALWAYS E88.8 | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION | Correlation | SNOMED CT source code to target map code correlation not specified |
|
|